Pleural effusion and thickening due to cabergoline use in a patient with Parkinson's disease

European Journal of Internal Medicine

Volumn 16, Issue 2, 2005, Pages 129-131

  Guptha, Sunku H ^a   Promnitz, Anthony D ^b  

^a EDITH CAVELL HOSPITAL   (United Kingdom)

^b IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

Cabergoline; Parkinson's disease; Pleural effusion; Pulmonary fibrosis

Indexed keywords

AMANTADINE; ANTIBIOTIC AGENT; CABERGOLINE; CARBIDOPA PLUS LEVODOPA; DOPAMINE RECEPTOR STIMULATING AGENT; ROPINIROLE;

AGED; ARTICLE; CASE REPORT; CAUCASIAN; DISEASE COURSE; DOSE RESPONSE; DYSKINESIA; HUMAN; INFLAMMATION; LABORATORY TEST; MALE; PARKINSON DISEASE; PATIENT; PLEURA BIOPSY; PLEURA EFFUSION; PLEURA THICKENING; TREATMENT OUTCOME;

EID: 17144386642     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2004.09.014     Document Type: Article

References (6)

1. C.E. Clarke, and K.H. Deane Cabergoline for levodopa-induced complications in Parkinson's disease Cochrane Database Syst Rev (Engl) 1 2001 CD001518
2. J.L. Montastruc, O. Rascol, and J.M. Senard Treatment of Parkinson's disease should begin with a dopamine agonist Mov Disord (US) 14 5 1999 (Sep.) 725 730
3. P. Pfitzenmeyer, P. Foucher, and G. Dennewald Pleuro-pulmonary changes induced by ergoline drugs Eur Respir J 9 1996 1013 1019
4. I. Claes, H. Slabbynck, L. Bedert, D. Galdermans, I. Dierckx, and D. Coolen A 47-year-old man with nonproductive cough and right-sided chest pain Eur Respir J 10 1997 2171 2173
5. P. De Vuyst, P. Pfitzenmeyer, and Ph. Camus Asbestos, ergot drugs and the pleura Eur Respir J 10 1997 2695 2698
6. S. Shaunak, A. Wilkins, J.B. Pilling, and D.J. Dick Pericardial, retroperitoneal and pleural fibrosis induced by pergolide J Neurol Neurosurg Psychiatry 66 1999 79 81